7 unknown. 7 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 7 |
| Phase 2 | 5 | Unknown 5 |
Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) Three-dimensional patient-specific bioprinting trachea implantation - Thyroid Cancer | Phase 1 / Phase 2 | Unknown | Ja Seong Bae, MD, phD | 1 | 2023-07-17 | 2023-09-25 |
| A Study of DB-1202 Monotherapy in Advanced Solid Tumors DB-1202 - Advanced Solid Tumor | Phase 1 / Phase 2 | Unknown | DualityBio Inc. | 150 | 2023-06-28 | 2023-03-31 |
| The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach TOETVA - Thyroid Diseases, Surgery | Phase 1 | Unknown | University Health Network, Toronto | 15 | 2019-12-01 | 2021-04-13 |
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors Phase 1 : Regorafenib, Phase 1 : Avelumab, Phase 2 : Regorafenib - Colorectal Cancer Not MSI-H or MMR-deficient, GIST | Phase 1 / Phase 2 | Unknown | Institut Bergonié | 747 | 2018-05-04 | 2023-03-03 |
| Role of the Microbiome in Graves' Orbitopathy LAB4 - Graves' Disease | Phase 1 / Phase 2 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 60 | 2015-02-01 | 2015-02-27 |
| the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake chinese herbs-I, chinese herbs-II - Thyroid Diseases | Phase 1 / Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 400 | 2012-06-01 | 2016-02-17 |
| Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer conventional surgery, radiofrequency ablation - Head and Neck Cancer | Phase 1 | Unknown | University of California, San Francisco | 2004-09-01 | 2013-09-20 |
Thyroid Neoplasms (3) · Biliary Tract Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Graves Disease (1) · Head and Neck Neoplasms (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Sarcoma (1) · Stomach Neoplasms (1) · Tertiary Lymphoid Structures (1)
Endocrine System Diseases (7) · Endocrine Gland Neoplasms (4) · Neoplasms (4) · Neoplasms by Site (4) · Head and Neck Neoplasms (3) · Adenocarcinoma (2) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Respiratory Tract Diseases (2) · Adenocarcinoma, Papillary (1) · Adenoma (1) · Autoimmune Diseases (1) · Biliary Tract Diseases (1)
Clinical Trials, Phase II as Topic (1) · Radiofrequency Ablation (1) · regorafenib (1)
DualityBio Inc. (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Institut Bergonié (1) · Ja Seong Bae, MD, phD (1) · Tianjin Medical University Cancer Institute and Hospital (1) · University Health Network, Toronto (1) · University of California, San Francisco (1)
Canada (1) · China (1) · France (1) · Italy (1) · South Korea (1) · United States (1)
Electron Kebebew, MD (1) · Jesse D Pasternak, MD (1) · Mario Salvi, MD (1) · Raymond Zhao (1) · Sung Won Kim, MD, PhD (1)
PMID 18299459, PMID 26041482, PMID 26163763, PMID 30261427, PMID 34965951, PMID 34998048, PMID 40204996, PMID 40579407
2016 (1)